Novartis oral Fabhalta secures USFDA okay for adults with C3 glomerulopathy Ruchika Sharma21 March 2025 12:42 PM ISTBasel: Novartis has announced that the U.S. Food and Drug Administration (FDA) has approved oral Fabhalta (iptacopan) for the treatment...
USFDA nod to JnJ Tremfya for Crohn's disease Ruchika Sharma21 March 2025 10:30 AM ISTHorsham: Johnson & Johnson has announced that the Company ahs received approval from the U.S. Food and Drug Administration (FDA) for TREMFYA...
Prioritize healthcare security through balanced tariff measures for medical devices: AiMeD urges Govt Ruchika Sharma20 March 2025 5:30 PM ISTAiMeD suggested India implement similar duties to protect the medical device supply chain and prepare for future health emergencies like COVID-19.
Recall of Medtronic embolization devices classified as most serious by USFDA Ruchika Sharma20 March 2025 4:45 PM ISTMedtronic's recall of embolization device has been classified most serious by the U.S. Food and Drug Administration (USFDA), citing potential risks of...
Aurobindo Pharma arm gets USFDA EIR for Telangana unit Ruchika Sharma20 March 2025 3:30 PM ISTTelangana: Apitoria Pharma Private Limited, a wholly owned subsidiary of Aurobindo Pharma, has received an Establishment Inspection Report...
Syngene concludes acquisition of biologics manufacturing facility from Emergent BioSolutions Ruchika Sharma20 March 2025 2:30 PM ISTBengaluru: Syngene International Limited has announced the conclusion of the acquisition of its first biologics site in the USA, which was announced...
Cipla gets exclusive rights to market ophthalmic drug across 11 countries Ruchika Sharma20 March 2025 1:30 PM ISTAPP13007 is a novel, patent protected and USFDA approved ophthalmic product.
Bajaj Healthcare gets CDSCO panel nod for Phase III trials for anti-seizure drug Ruchika Sharma20 March 2025 12:30 PM IST"With this, Bajaj Healthcare aims to provide a safe and effective treatment option for epilepsy patients in India," the Company stated.
Sanofi to buy Autoimmune Disease treatment from Dren Bio for up to USD 1.9 billion Ruchika Sharma20 March 2025 11:30 AM ISTParis: Sanofi and Dren Bio, Inc., a private clinical-stage biopharmaceutical company, have entered into a definitive agreement under which Sanofi...
Marksans Pharma Goa facility gets Australian nod to manufacture pharma formulations for Australian markets Ruchika Sharma20 March 2025 10:30 AM ISTMumbai: Marksans Pharma Limited has announced that its manufacturing facility located at Plot A-1, Phase 1-A, Verna Industrial Estate, Verna,...
Pfizer to exit Haleon Ruchika Sharma19 March 2025 6:30 PM ISTBengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare group.As part of the...
Synokem Pharmaceutical Gets CDSCO Panel Nod To study Tofacitinib Extended Release Tablets Dr. Divya Colin19 March 2025 6:00 PM ISTNew Delhi: Synokem Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
